Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Clinicians share insights to shape AI support for breast cancer patients

NCT ID NCT07644845

Knowledge-focused Sponsor: University of Central Florida Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study asks 12 clinicians in Florida who care for women with breast cancer about gaps in emotional and mental health support. They will join virtual focus groups and fill out a short survey. The goal is to use their insights to build an AI-powered digital platform called MammoVerse that could offer emotional support, peer connection, and better healthcare engagement.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could guide the development of an AI-based digital platform to improve emotional support and peer connection for breast cancer patients.
What could go wrong
This is a very small, early-stage study (12 clinicians) that only collects opinions, not patient data. The AI platform is not yet built, so benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Recruitment will be through targeted outreach to clinicians providing breast cancer care in Florida. Invitations will be distributed via email to University of Central Florida College of Medicine UCF COM faculty, affiliated faculty and clinical partners over the recruitment period. Interested clinicians will be provided with study information and instructions for contacting the research team as well as accessing the online consent and enrollment materials. Interested clinicians will enroll online, and provide their information for scheduling the focus group meeting.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * they are an adult (over 18) * physician (MD or DO), licensed psychologist (PhD or PsyD), advanced practice provider (ARNP or PA), nurse (RN or LPN), licensed clinical social worker (LCSW) or other licensed clinician * provide specialized cancer care to women diagnosed with breast cancer in Florida * can provide informed consent * are self-reporting that they licensed clinicians * are self-reporting that they are physically able to participate in a 60-minute group discussion. Exclusion Criteria: * This study will NOT include persons under the age of 18, prisoners, and persons unable to speak English fluently, and persons unable to provide informed consent. We are not able to accommodate non-English speakers as this is a pilot study involving group discussion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Central Florida

    Orlando, Florida, 32827, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.